Privium Fund Management’s Celularity Inc CELUW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,006,916
Closed -$50.3K 119
2023
Q4
$50.3K Sell
1,006,916
-20,332
-2% -$350 0.01% 93
2023
Q3
$15.6K Sell
1,027,248
-23,874
-2% -$821 ﹤0.01% 98
2023
Q2
$61.8K Sell
1,051,122
-358,493
-25% -$21.7K 0.02% 89
2023
Q1
$84.6K Sell
1,409,615
-206,597
-13% -$17.2K 0.03% 86
2022
Q4
$105K Sell
1,616,212
-94,409
-6% -$20.7K 0.04% 77
2022
Q3
$547K Sell
1,710,621
-12,406
-0.7% -$5.39K 0.2% 59
2022
Q2
$995K Buy
1,723,027
+51,595
+3% +$50.8K 0.33% 45
2022
Q1
$2.29M Buy
1,671,432
+998,516
+148% +$813K 0.51% 42
2021
Q4
$572K Buy
+672,916
New +$682K 0.11% 74

Other funds holding CELUW

Privium Fund Management's CELUW Position: Q1 2024 in Review

Privium Fund Management sold out of Celularity Inc (CELUW) in Q1 2024, closing a stake of 1,006,916 shares — an estimated $50.3K sold.

Privium Fund Management first reported a position in CELUW in Q4 2021 and held it in 9 quarters. The position peaked at $2.29M in Q1 2022. 12 funds tracked by Wall St. Rank hold CELUW as of Q1 2024.

  • Privium Fund Management reported no remaining Celularity Inc position as of Q1 2024 after selling out during the quarter.
  • Privium Fund Management sold 1,006,916 Celularity Inc shares in Q1 2024, an estimated $50.3K.
  • Privium Fund Management first reported a position in Celularity Inc in Q4 2021 and held it in 9 quarters.
  • Privium Fund Management's Celularity Inc position peaked at $2.29M in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Celularity Inc as of Q1 2024.

Based on Privium Fund Management's 13F filing for Q1 2024, filed 30 Apr 2024.